Metraipolis › archive › dc_e2115369a4e9

Real-world experience of Dolutegravir/Lamivudine for rapid initiation of antiretroviral therapy among treatment-naïve HIV-1-infected adults in China: a… — Europe PMC PMID:41756385

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41756385
DOI
10.3389/fmed.2026.1759609
License (as archived)
solo-consultazione
Archived
2026-11-05T22:35:30.526Z
SHA-256 of the archived text
1be73a019898e35e7f015c48b29db2d1985b3e10de25bc6019cce0c739210099
Stable URL of this page
https://metraipolis.com/documento/dc_e2115369a4e9

How to cite

Real-world experience of Dolutegravir/Lamivudine for rapid initiation of antiretroviral therapy among treatment-naïve HIV-1-infected adults in China: a… — Europe PMC PMID:41756385 — Europe PMC (en), https://europepmc.org/article/MED/41756385 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e2115369a4e9 (Metraipolis archive dc_e2115369a4e9, sha256 1be73a019898e35e7f015c48b29db2d1985b3e10de25bc6019cce0c739210099)
BibTeX
@misc{dce2115369a4e9,
  title = {Real-world experience of Dolutegravir/Lamivudine for rapid initiation of antiretroviral therapy among treatment-naïve HIV-1-infected adults in China: a… — Europe PMC PMID:41756385},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41756385},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e2115369a4e9; sha256 1be73a019898e35e7f015c48b29db2d1985b3e10de25bc6019cce0c739210099},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41756385. Agents can read the archived copy with the MCP tool read_document.